Home Newsfeeds Raymond James Downgrades SkyWest to Underperform

Raymond James Downgrades SkyWest to Underperform

Raymond James analyst Savanthi Syth downgrades SkyWest (NASDAQ:SKYW) from Market Perform to Underperform.

byBenzinga Newsdesk

September 8, 2022

1 minute read

Raymond James analyst Savanthi Syth downgrades SkyWest (NASDAQ:SKYW) from Market Perform to Underperform.

Economist React To May Retail Sales Data: ‘Consumer Spending Is Cooling In A Fairly Orderly Fashion’

By Michael Juliano

June 18, 12:44 PM

US retail sales for May missed expectations, raising concerns about economic growth. Resilient consumer spending has been a key factor in the bull market.

AMZN

News
Tech

Tim Cook’s Apple Goes All-In On AI Talent Search While Steve Wozniak Continues To Lead Battle Against Unhindered AI Development

By Ananya Gairola

May 20, 7:57 AM

In an ever-evolving landscape of artificial intelligence, or AI,Â Apple Inc.‘sÂ (NASDAQ:AAPL) reported pursuit of generative artificial intelligence talent contrasts…

AAPL

Leidos Wins $631M Sensor Contract From U.S. Army

By Benzinga Newsdesk

May 7, 8:07 AM

Leidos, a science and technology innovator, recently received a $631 million award from the U.S. Army Contracting Command – Aberdeen Proving Grounds. The Development, Integration, Acquisitions, Bridging to Logistics

LDOS

Popular Weight Loss Drugs Ozempic and Wegovy Alert: FDA Adds Intestinal Blockage Warning

By Vandana Singh

September 27, 11:52 AM

In a significant development, the FDA has updated the labeling for Novo Nordisk A/S's (NYSE: NVO) Ozempic, a diabetes drug known for its weight loss side effect, to include warnings about reports of blocked intestines

LLY

Raymond James Downgrades SkyWest to Underperform

Related Posts

Economist React To May Retail Sales Data: ‘Consumer Spending Is Cooling In A Fairly Orderly Fashion’

Tim Cook’s Apple Goes All-In On AI Talent Search While Steve Wozniak Continues To Lead Battle Against Unhindered AI Development

Leidos Wins $631M Sensor Contract From U.S. Army

Popular Weight Loss Drugs Ozempic and Wegovy Alert: FDA Adds Intestinal Blockage Warning